Q71L (p.Gln71Leu) variant of UBQLN2 (Ubiquilin-2)
Q71L (p.Gln71Leu) in UBQLN2 (Ubiquilin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The record also includes variant effect predictions and structural context.
Q71L (p.Gln71Leu) variant details
- p.Gln71Leu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Missense
- MetaLR 0.56
- MetaSVM 0.14
- SIFT 0.03
- UniProt: Variant assessed as somatic; high impact.
- Structural context available